Skip to main content
OpenTrials
Completed

NCT Number: NCT05766462

Allometric-Pace Study

The goal of this observational study is to improve quality of life in sinus node dysfunction patients by utilizing allometric lower rate pacing (or called personalized lower rate, PLR) in standard commercially available dual-chamber pacemakers.

The primary objective is to achieve a significant improvement in patients' quality of life with use of PLR pacing in comparison with the control group with nominal lower rate in patients with implanted dual-chamber pacemaker.

The secondary objectives are to assess cardiac functional changes in echocardiography of ventricular mechanical performance with a PLR pacing in comparison with the control group with nominal lower rate, and to assess the viability of using elevated blood pressure as a marker for undetected bradycardia and providing allometric rate to correct bradycardia-related increase in arterial systolic blood pressure.

Completed

Looking for future studies?

Notify Me

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, China

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients are at age of equal to or more than 60 years old
  • Patients have plan to implant dual-chamber pacemaker
  • Resting sinus heart rate is equal or less than 60 bpm, or average heart rate detected through 24-hour dynamic electrocardiogram is equal or less than 60 bpm
  • Patients have diagnosis of SND. If patients have both sinus node dysfunction and AV block, conduction system pacing shall be available
  • Patients have a history of hypertension, two times of blood pressure measurements at office visit are equal to or more than 130 mmHg in systolic blood pressure, diastolic pressure is equal or less than 80 bpm

Exclusion criteria

  • Patients have or possible concomitant a diagnosis of heart failure, either reduced EF or preserved EF
  • Patients have persistent or chronic atrial fibrillation or clinically significant paroxysmal atrial fibrillation
  • Previously diagnosed with a history of organic heart disease: including congenital heart disease, coronary heart disease, old myocardial infarction, dilated cardiomyopathy, hypertrophic cardiomyopathy, cardiac amyloidosis, long QT syndrome, etc.
  • Patients have a known secondary cause of hypertension
  • Patients have hospitalization of a hypertensive emergency in the previous year
  • Patients have a history of renal disease or renal-artery diseases
  • Severe hepatic or renal dysfunction
  • Active acute infection
  • Patients cannot submit a signed informed consent form
  • Patients are pregnant or plan to be pregnant during study period
  • Patients participate in another study that will confound this study

Treatment and study plan

Pacemaker lower rate setting

Other

Pacemaker lower rate is set by physician and may be adjusted according to the physician diagnosis.

Primary outcomes

  1. Life quality measurement

    Time frame: Within three months after the surgery

    SF-36 questionnaire score will be used as the criteria.

Secondary outcomes

  1. Cardiac functional changes

    Time frame: Within three months after the surgery

    LVEF will be measured

  2. To assess the correlation of elevated blood pressure and bradycardia.

    Time frame: Within three months after the surgery

    24 hour ambulatory blood pressure will be measured.

Sponsors and collaborators

Lead sponsor

Medtronic Cardiac Rhythm and Heart Failure

Industry

Registry information

Official study title

Utilization of Personalized Pacing to Improve Quality of Life in Sinus Node Dysfunction Patients

Important dates

Study start
2023
Primary completion
2024
Study completion
2025
First posted
Mar 13, 2023
Registry last updated
Feb 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.